Can IBM close the gap with tech sector as stock approaches key resistance?
Divergence between an individual stock and its broader sector rarely persists indefinitely, especially when the technical picture starts to improve. For IBM, the key question now is whether that relative weakness begins to narrow or becomes even more pronounced.
Market leadership within the S&P 500 remains fairly narrow. Only two sectors currently have stocks trading at both 4-week and 52-week highs: health care and information technology. In the technology sector, 29% of stocks are at 4-week highs and 5% are at 52-week highs, while the corresponding figures for health care are 20% and 8%.
Against that backdrop, IBM has significantly lagged the broader technology sector. Since the September 14 close, the stock has fallen 7.1%. Over the same period, the Technology Select Sector SPDR Fund (XLK) has gained 6.5%, leaving a performance gap of roughly 13.6 percentage points between IBM and the sector.
That divergence could create room for a catch-up move if selling pressure in IBM continues to ease. Any such scenario, however, still requires confirmation from price action.

Trendline breakout could reopen the path toward $242
IBM continues to follow the recovery scenario outlined earlier. The stock held above the $227.50–$230 support zone and moved back above the 50-day SMA, which currently sits near $230.20. That keeps the path toward resistance at $242 open.
For today’s session, $233.50 is the key level to watch. A short-term descending trendline runs close to that area.
A breakout and sustained move above it would provide an additional signal that the recovery is gaining traction, with $242 remaining the next target.
A sustained move below the 50-day SMA and $227.50 would invalidate the setup. In that case, the risk of a deeper decline toward $215 would rise sharply.

IBM still needs price confirmation to close the gap with tech
IBM’s current setup stands out mainly because of two factors: its pronounced underperformance relative to the technology sector and the gradual improvement in its short-term technical structure.
The gap with XLK alone does not mean IBM shares will necessarily begin to catch up with the sector. The market still needs evidence that buyers are returning, with a break above the descending trendline near $233.50 serving as the key confirmation signal.
If that level is cleared, the case for a move toward $242 would gain further support. Until then, IBM remains in a transitional phase, where the potential for a recovery is beginning to take shape but a definitive signal has yet to emerge.